X0508 4 2026-02-27 false 0001645113 NovoCure Ltd NVCR 0001811030 Weinberg Uri C/O NOVOCURE INC. 1550 LIBERTY RIDGE DRIVE, SUITE 115 WAYNE PA 19087 false true false false Chf Medical and Innovation Ofr false Ordinary Shares 2026-02-27 4 S false 7461.00 13.8395 D 213757.00 D Ordinary Shares 2026-02-28 4 A false 12992.00 0.00 A 226749.00 D Ordinary Shares 2026-03-02 4 S false 3272.00 13.3273 D 223477.00 D Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person. This transaction was executed in multiple trades at prices ranging from $13.79 USD to $13.91 USD; the price reported above reflects the weighted average sale price. Represents vesting of performance-based restricted stock units. This transaction was executed in multiple trades at prices ranging from $13.31 USD to $13.36 USD; the price reported above reflects the weighted average sale price. Steven Robbins, as attorney in fact for Weinberg, Uri 2026-03-03